By mid-February 2020, new questions surfaced about whether the novel coronavirus could be traced back to scientific research conducted in Wuhan labs, a subject that had been widely discussed since January after the outbreak in China emerged. According to a February 16, 2020 report in the Daily Mail, South China University of Technology scientists wrote a paper questioning whether research on bats and respiratory diseases at the Wuhan Institute of Virology and the Wuhan Centers for Disease Control (WCDC) had created a new chimeric coronavirus capable of infecting humans. The WCDC is located just 300 yards from the fish and wildlife food market thought to be the origin of the coronavirus and is adjacent to the Union Hospital where the first group of doctors were infected.
On February 15, 2020, a paper was published in The Lancet by Chinese scientists, “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.” In this paper, the authors stated that “In December, 2019, a series of pneumonia cases of unknown cause emerged in Wuhan, Hubei, China, with clinical presentations greatly resembling viral pneumonia” and they described 41 cases hospitalized by January 2, 2020, of which 66 percent (27 people) had been exposed to the food market and 15 percent (6 people) died.
As questions about the origin of the virus began circulating, WHO quickly endorsed the theory that it had spontaneously jumped from animals, most likely bats, to humans in the Wuhan market selling seafood and wildlife animals, additionally, the WHO stated that online speculation to the contrary was “misinformation.” In early February 2020, it was reported that WHO had teamed up with Google to battle online “misinformation” about the SARS-CoV-2 epidemic, and additional meetings included many big tech companies.
In January 2021, Dr. John Dye, Chief of Viral Immunology for the U.S. Army Medical Research Institute of Infectious Diseases, was interviewed and asked what was known about the origins of SARS-CoV-2 and if the Wuhan lab in China had been ruled out. His response was “No, at this point, nothing has been ruled out. We do not know. It is undetermined whether it was from a laboratory or from an environmental exposure, at this point in time, and we probably never will know.”
By mid-February 2021, controversy was fueled as revelations by a lead infectious disease expert traveling to Wuhan as a member of an international delegation from the WHO stated that only summary data on early cases were provided to the delegation. Dr. Dwyer added that it was standard practice in an outbreak investigation for raw data to be shared and had yet to be provided by China.
In an interview on CNN in late March 2021, former CDC Director Robert Redford, MD stated that it was his opinion that the SARS-CoV-2 virus originated in a laboratory in Wuhan China, and transmission had already begun by September or October of 2019.
Additional investigative reports have provided evidence to support the lab origin theory and have suggested that the U.S. and China were involved in research involving genetic manipulation of bat coronavirus in an attempt to create vaccines and therapeutics. From information uncovered, evidence has found that these projects were funded by U.S. taxpayers and paid out by National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Diseases (NIAID), and the U.S. Agency for International Development (USAID). Reports have also noted that those who have fought hard to debunk the COVID-19 lab origin theory have ties to the vaccine research and funding partnerships with the Wuhan Institute of Virology (WIV).
In early May 2021, multiple federal legislators requested that the lab origin theory be fully investigated and have requested information on the U.S funding of research completed at the WIV.
In September 2021, The Intercept announced that it had received over 900 pages of documents outlining the work of EcoHealth Alliance, an organization based in the U.S. that used money from federal agencies to fund bat coronavirus research at the Wuhan Institute of Virology. The documents were made available to the public for review as part of ongoing Freedom of Information Act (FOIA) legislation.
The released data revealed that experiments on bat coronaviruses took place at the biosafety Level 3 lab at the Wuhan University Center for Animal Experiment and not the WIV. Grant funding, which totaled $3.1 million, also included nearly $600,000 that was used by the WIV to identify and alter bat coronaviruses that had the capability to infect humans.
NIAID Director Dr. Anthony Fauci has continually denied that his agency funded bat coronavirus research at the WIV. However, in mid-October 2021, the NIH changed their story and confirmed that they had funded studies in Wuhan that made bat coronavirus more virulent.
In September 2022, the Lancet published a paper which suggested that SARS-CoV-2 may have originated in a laboratory from experiments on similar coronaviruses. This paper contradicted their conclusions from 2020, which stated that individuals who did not believe that the virus evolved from a bat were conspiracy theorists and spreading misinformation.